Xolair and Cefuroxime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xolair (omalizumab) and Cefuroxime (cefuroxime sodium). Common drug interactions include bronchiectasis among females and nasopharyngitis among males.

The phase IV clinical study analyzes what interactions people have when they take Xolair and Cefuroxime. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Xolair?

Xolair has active ingredients of omalizumab. It is often used in asthma. eHealthMe is studying from 77,554 Xolair users. Check the latest studies of Xolair.

What is Cefuroxime?

Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. eHealthMe is studying from 12,999 Cefuroxime users. Check the latest studies of Cefuroxime.

On Jul, 21, 2026

53 people who take Xolair and Cefuroxime together, and have interactions are studied.

Xolair and Cefuroxime drug interactions.

What are the common drug interactions of Xolair and Cefuroxime, by gender? *:

female:

Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Heart rate increased
Injection site bruising
Injection site urticaria (rash of round, red welts on the skin at injection site)
Intervertebral disc degeneration (spinal disc degeneration)
Intervertebral disc protrusion (spinal disc protrusion)

male:

Nasopharyngitis (inflammation of the nasopharynx)
Wheezing (a high-pitched whistling sound made while you breath)
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Lower respiratory tract infection
Malaise (a feeling of general discomfort or uneasiness)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Arthralgia (joint pain)
Breath sounds
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Fatigue (feeling of tiredness)

What are the common drug interactions of Xolair and Cefuroxime, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Arthralgia (joint pain)
Breath sounds
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Fatigue (feeling of tiredness)
Heart rate increased
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Pain in extremity
Sluggishness (lacking alertness)
Upper respiratory tract infection

30-39:

Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Headache (pain in head)
Heart rate decreased
Heart rate increased
Injection site bruising
Injection site urticaria (rash of round, red welts on the skin at injection site)
Intervertebral disc degeneration (spinal disc degeneration)
Intervertebral disc protrusion (spinal disc protrusion)

40-49:

Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Cardiac disorder
Headache (pain in head)
Infusion related reaction
Lung infection
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

50-59:

Productive cough
Rales (an abnormal respiratory sound characterized by fine crackles)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cough
Dyspnoea (difficult or laboured respiration)
Ear congestion
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Influenza
Lower respiratory tract infection
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)

60+:

Nasopharyngitis (inflammation of the nasopharynx)
Dyspnoea (difficult or laboured respiration)
Forced expiratory volume decreased (decreased lung expired air volume)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Heart rate decreased
Heart rate increased
Heart rate irregular
Lower respiratory tract infection
Mitral valve disease (disease of mitral valve of heart)
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)

What are the existing conditions these people have? *

Lower Respiratory Tract Infection: 7 people, 13.21%
Immunodeficiency Common Variable: 7 people, 13.21%
Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 4 people, 7.55%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 4 people, 7.55%
Fungal Infection: 4 people, 7.55%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 3 people, 5.66%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Xolair and Cefuroxime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously